Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 26

Results For "Government-of-India"

268 News Found

PerkinElmer to donate 1 million rapid COVID-19 antigen test kits in India
News | May 07, 2021

PerkinElmer to donate 1 million rapid COVID-19 antigen test kits in India

Much-needed diagnostics supplies will help accelerate testing capabilities of hospitals and clinics across India


Govt. gives order for 16 cr COVID-19 vaccine doses
News | May 04, 2021

Govt. gives order for 16 cr COVID-19 vaccine doses

As of 2nd May 2021, the Government has provided more 16.54 crore COVID-19 vaccine doses to States/UTs free of cost


India to import 450,000 vials of Remdesivir
News | May 01, 2021

India to import 450,000 vials of Remdesivir

The Government of India has started importing the vital drug Remdesivir from other countries to ease out the shortage of Remdesivir in the country


Indian vaccine players to garner Rs. 70,599 Cr in 2021
News | April 30, 2021

Indian vaccine players to garner Rs. 70,599 Cr in 2021

Riding COVID-19 wave, Indian vaccine industry set to be Rs. 700 billion strong


Govt. approves 25 manufacturing sites for Remdesivir production
News | April 26, 2021

Govt. approves 25 manufacturing sites for Remdesivir production

The production capacity is now ramped up to 90 lakh vials per month whereas earlier it was 40 lakh vials/month


Ports waive-off all charges for ships carrying oxygen
News | April 26, 2021

Ports waive-off all charges for ships carrying oxygen

Port chairpersons have been asked to personally supervise logistic operations to ensure unhindered movement of such consignments for berthing of such vessel on top priority in the port


Prime Minister holds high level meeting on oxygen
News | April 23, 2021

Prime Minister holds high level meeting on oxygen

Against the present demand from 20 states of 6,785 MT/day of Liquid Medical Oxygen, the Government of India has from 21st April allocated 6,822 MT/day to these states


Sputnik V needs to be priced at par with Covishield & Covaxin
News | April 23, 2021

Sputnik V needs to be priced at par with Covishield & Covaxin

Market penetration of Sputnik V will depend on competitive pricing, government orders and the ability to meet soaring demand through timely supply


Serum not contracted for complete production of COVID vaccine to centre
News | April 23, 2021

Serum not contracted for complete production of COVID vaccine to centre

These media reports are based on incorrect facts and are without any basis.


PM urges vaccine manufacturers to scale production capacity
News | April 21, 2021

PM urges vaccine manufacturers to scale production capacity

The country has constantly worked with the spirit of public-private partnership